Oruka Therapeutics (ORKA)
NASDAQ:ORKA
Holding ORKA?
Track your performance easily

Oruka Therapeutics (ORKA) Financial Statements

571 Followers

Oruka Therapeutics Financial Overview

Oruka Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.964; its P/E ratio is -4.44; Oruka Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.68M$ -2.01M$ -1.59M$ -1.42M$ -1.48M
EBITDA$ -2.67M$ -1.99M$ -1.57M-$ -1.48M
Net Income Common Stockholders$ -2.68M$ -2.01M$ -1.09M$ -1.42M$ -1.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.28M$ 35.90M$ 37.43M$ 38.49M$ 40.16M
Total Assets$ 33.84M$ 36.71M$ 37.86M$ 39.18M$ 41.08M
Total Debt$ 0.00$ 0.00$ 204.00K$ 224.00K$ 243.00K
Net Debt$ -33.28M$ -35.90M$ -37.23M$ -38.26M$ -39.91M
Total Liabilities$ 1.27M$ 1.58M$ 841.00K$ 1.22M$ 1.84M
Stockholders Equity$ 32.57M$ 35.13M$ 37.02M$ 37.97M$ 39.24M
Cash Flow-
Free Cash Flow$ -2.63M$ -1.53M$ -1.06M-$ -1.48M
Operating Cash Flow$ -2.63M$ -1.53M$ -1.06M$ -1.67M$ -1.48M
Investing Cash Flow-----
Financing Cash Flow$ 14.00K----
Currency in USD

Oruka Therapeutics Earnings and Revenue History

Oruka Therapeutics Debt to Assets

Oruka Therapeutics Cash Flow

Oruka Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis